Literature DB >> 19367342

Polymorphism in Carbamazepine Cocrystals.

William W Porter1, Sophia C Elie, Adam J Matzger.   

Abstract

Cocrystals of carbamazepine with nicotinamide and saccharin are shown to be polymorphic. Two polymorphs of carbamazepine-nicotinamide (CBZ-NCT) cocrystals and two polymorphs of carbamazepine-saccharin (CBZ-SAC) cocrystals were grown from solution in the presence of polymer heteronuclei. The two CBZ-NCT polymorphs, CBZ-NCT I and a polymer nucleated (PN) form of CBZ-NCT, were characterized by Raman spectroscopy and powder X-ray diffraction. CBZ-SAC II, a new polymorph, was found to be in the monoclinic space group C2/c with a = 35.72 Å, b = 6.84 Å, c = 16.11 Å, and β = 98.03°. The unique feature of CBZ-SAC II is the formation of a heterosynthon between the carbamazepine and saccharin. These results are notable because CBZ-NCT and CBZ-SAC are among the most widely studied pharmaceutical cocrystals.

Entities:  

Year:  2008        PMID: 19367342      PMCID: PMC2668533          DOI: 10.1021/cg701022e

Source DB:  PubMed          Journal:  Cryst Growth Des        ISSN: 1528-7483            Impact factor:   4.076


  11 in total

1.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

2.  Polymer-induced heteronucleation for the discovery of new extended solids.

Authors:  Adam L Grzesiak; Fernando J Uribe; Nathan W Ockwig; Omar M Yaghi; Adam J Matzger
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-10       Impact factor: 15.336

3.  Selection and discovery of polymorphs of platinum complexes facilitated by polymer-induced heteronucleation.

Authors:  Adam L Grzesiak; Adam J Matzger
Journal:  Inorg Chem       Date:  2007-01-22       Impact factor: 5.165

4.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

5.  Crystalline polymorph selection and discovery with polymer heteronuclei.

Authors:  Christopher P Price; Adam L Grzesiak; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

Review 6.  Pharmaceutical co-crystals.

Authors:  Peddy Vishweshwar; Jennifer A McMahon; Joanna A Bis; Michael J Zaworotko
Journal:  J Pharm Sci       Date:  2006-03       Impact factor: 3.534

7.  Performance comparison of a co-crystal of carbamazepine with marketed product.

Authors:  Magali B Hickey; Matthew L Peterson; Lisa A Scoppettuolo; Sherry L Morrisette; Anna Vetter; Hector Guzmán; Julius F Remenar; Zhong Zhang; Mark D Tawa; Sean Haley; Michael J Zaworotko; Orn Almarsson
Journal:  Eur J Pharm Biopharm       Date:  2006-12-28       Impact factor: 5.571

8.  Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.

Authors:  K Seefeldt; J Miller; F Alvarez-Núñez; N Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

9.  New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer-induced heteronucleation.

Authors:  Adam L Grzesiak; Adam J Matzger
Journal:  J Pharm Sci       Date:  2007-11       Impact factor: 3.534

10.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.

Authors:  Adam L Grzesiak; Meidong Lang; Kibum Kim; Adam J Matzger
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

View more
  14 in total

Review 1.  Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.

Authors:  Dipak Dilip Gadade; Sanjay Sudhakar Pekamwar
Journal:  Adv Pharm Bull       Date:  2016-12-22

2.  Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

Review 3.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

4.  Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.

Authors:  Ziyaur Rahman; Cyrus Agarabi; Ahmed S Zidan; Saeed R Khan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2011-05-20       Impact factor: 3.246

5.  On the mechanism of crystalline polymorph selection by polymer heteronuclei.

Authors:  Vilmalí López-Mejías; Jennifer L Knight; Charles L Brooks; Adam J Matzger
Journal:  Langmuir       Date:  2011-05-19       Impact factor: 3.882

6.  Peering at a buried polymer-crystal interface: probing heterogeneous nucleation by sum frequency generation vibrational spectroscopy.

Authors:  Arthur A McClelland; Vilmalí López-Mejías; Adam J Matzger; Zhan Chen
Journal:  Langmuir       Date:  2011-02-15       Impact factor: 3.882

7.  Cyanoximes as effective and selective co-crystallizing agents.

Authors:  Christer B Aakeröy; Debra J Salmon; Michelle M Smith; John Desper
Journal:  CrystEngComm       Date:  2009-01-01       Impact factor: 3.545

8.  Thermal Analysis Investigation of Dapoxetine and Vardenafil Hydrochlorides using Molecular Orbital Calculations.

Authors:  Ali Kamal Attia; Eglal R Souaya; Ethar A Soliman
Journal:  Adv Pharm Bull       Date:  2015-11-30

9.  Pharmaceutical Cocrystals and Their Physicochemical Properties.

Authors:  Nate Schultheiss; Ann Newman
Journal:  Cryst Growth Des       Date:  2009-04-20       Impact factor: 4.076

Review 10.  Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.

Authors:  Isabela Fanelli Barreto Biscaia; Samantha Nascimento Gomes; Larissa Sakis Bernardi; Paulo Renato Oliveira
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.